Lombard Odier Asset Management Europe Ltd Trims Stock Position in Corteva, Inc. $CTVA

Lombard Odier Asset Management Europe Ltd lessened its stake in Corteva, Inc. (NYSE:CTVA) by 93.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 188,474 shares of the company’s stock after selling 2,796,785 shares during the quarter. Lombard Odier Asset Management Europe Ltd’s holdings in Corteva were worth $12,633,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of CTVA. Norges Bank purchased a new position in Corteva in the fourth quarter valued at $504,001,000. Northwestern Mutual Wealth Management Co. increased its position in shares of Corteva by 6,527.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after buying an additional 3,100,709 shares in the last quarter. Perpetual Ltd raised its stake in shares of Corteva by 78,688.5% during the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock worth $175,336,000 after buying an additional 2,612,459 shares during the period. Amundi lifted its position in shares of Corteva by 125.3% during the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after buying an additional 1,899,248 shares in the last quarter. Finally, Squarepoint Ops LLC lifted its position in shares of Corteva by 423.6% during the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after buying an additional 1,406,199 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 1.5%

CTVA stock opened at $76.84 on Wednesday. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The firm has a market cap of $51.39 billion, a PE ratio of 45.20, a PEG ratio of 2.32 and a beta of 0.57. The firm’s 50 day moving average price is $80.02 and its 200-day moving average price is $75.52. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Wall Street Analysts Forecast Growth

CTVA has been the topic of a number of research reports. Wells Fargo & Company raised their price target on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, April 21st. UBS Group dropped their price target on Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research report on Tuesday, June 9th. Barclays raised their price objective on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. Mizuho lifted their target price on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Finally, Jefferies Financial Group increased their target price on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $88.81.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.